Zhangding Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 10
- Circular RNAs in diseases 5
- Cancer-related gene regulation 4
- RNA Research and Splicing 4
-
- Cancer-related molecular mechanisms research 11
- Cancer, Lipids, and Metabolism 5
- Co-authors
- Shouyu Wang (21 shared papers)Qiang Wang (20 shared papers)Chen Chen (6 shared papers)Jianwei Zhou (8 shared papers)Xiaoping Zou (5 shared papers)Junjie Chen (4 shared papers)Qingqing Ding (4 shared papers)Beicheng Sun (5 shared papers)
- Journals
- Cancer Letters (2 papers)Cell Death Discovery (2 papers)Advanced Science (2 papers)Gut (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhangding Wang
37 papers receiving 1.6k citations
Zhangding Wang's Hit Papers
Peers
Comparison fields: 5 of 63
- Cancer Research 762
- Molecular Biology 1.2k
- Oncology 153
- Pulmonary and Respiratory Medicine 95
- Immunology 47
Countries citing papers authored by Zhangding Wang
This map shows the geographic impact of Zhangding Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhangding Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhangding Wang more than expected).
Fields of papers citing papers by Zhangding Wang
This network shows the impact of papers produced by Zhangding Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhangding Wang. The network helps show where Zhangding Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhangding Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | METTL3-mediated m 6 A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance Hit paper breakdown → | 2019 | 641 |
| 2 | 2018 | 123 | |
| 3 | 2020 | 90 | |
| 4 | 2020 | 88 | |
| 5 | 2022 | 78 | |
| 6 | 2022 | 64 | |
| 7 | 2019 | 53 | |
| 8 | 2020 | 51 | |
| 9 | 2022 | 51 | |
| 10 | 2021 | 42 | |
| 11 | 2023 | 37 | |
| 12 | 2017 | 26 | |
| 13 | 2018 | 25 | |
| 14 | 2017 | 25 | |
| 15 | 2021 | 21 | |
| 16 | 2023 | 15 | |
| 17 | 2024 | 14 | |
| 18 | 2017 | 14 | |
| 19 | 2021 | 14 | |
| 20 | 2025 | 13 |
About Zhangding Wang
Zhangding Wang is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (10 papers), Circular RNAs in diseases (5 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer-related gene regulation (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), RNA Research and Splicing (4 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (762 citations), Molecular Biology (1.2k citations), Oncology (153 citations), Pulmonary and Respiratory Medicine (95 citations) and Immunology (47 citations). Zhangding Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shouyu Wang, Qiang Wang, Chen Chen, Jianwei Zhou, Xiaoping Zou, Junjie Chen, Qingqing Ding, Beicheng Sun, Guifang Xu and Yan Zhang. Their work appears in journals such as Cancer Letters, Cell Death Discovery, Advanced Science, Gut and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.